GlaxoSmithKline's CFO, Simon Dingemans, discusses sales growth and strong cash generation in the third quarter, research and development activity, as well as emerging markets and China.
Read Next
A Humble Oyster Pail Turned Takeout Icon
October 20, 2026






















